|
Biomarker
|
Intervention (exposure)
|
Change
|
|---|
|
N
|
F-statistic
|
p value
|
|---|
|
Free reduced GSHa
|
|
15 weeks
|
40
|
1.95
|
0.170
|
–
|
|
30 weeks
|
22
|
0.75
|
0.485
| |
|
Total GSHa
|
|
15 weeks
|
40
|
0.11
|
0.746
|
–
|
|
30 weeks
|
22
|
0.06
|
0.946
| |
|
GSSGa
|
|
15 weeks
|
40
|
0.15
|
0.701
|
↑
|
|
30 weeks
|
22
|
2.32
|
0.124
| |
|
Free GSH:GSSG
|
|
15 weeks
|
40
|
3.90
|
0.055
|
↓
|
|
30 weeks
|
22
|
8.12
|
0.003
| |
|
Total GSH:GSSG
|
|
15 weeks
|
40
|
1.32
|
0.258
|
↓
|
|
30 weeks
|
22
|
3.60
|
0.046
| |
- Bold signifies p < 0.05
- MANOVA test for repeated measures (compared to baseline at 0 weeks); analysis includes participants from the initial PL group while they were on SF at 22 and 30 weeks (their first 7 and 15 weeks of exposure)
- aNatural log transformed
